The UC Lung Cancer Consortium (UCLCC) puts cutting-edge research, translational medicine and clinical practice from UC’s five NCI-designated Comprehensive Cancer Centers to bear on prevention, personalized treatment and care for all Californians, especially the state’s most vulnerable populations.
Clinical trials and projects
Lung cancer clinical trials across the UC system
Lung Cancer Consortium Quarterly Young Investigators and Journal Club
January 9, 2024 5:30pm PT
Speakers: Elisa Tong, M.D., M.A. and Britany Lundberg, M.D., UC Davis
Title: Tobacco History Population Data Issues and American Cancer Society's Lung Cancer Screening Guidelines
Registration and additional details available here.
For more information about upcoming meetings, contact Pauline McAlpin.
The UC Lung Cancer Consortium supports projects that encourage collaboration among UC campuses. For additional information, contact Pauline McAlpin.
Novel Multi-Omics Ultra-short ctDNA for Early Detection of NSCLC: David Wong, M.D. (UCLA)
Targeting TIGIT in Malignant Pleural Mesothelioma: Tianhong Li, M.D. (UC Davis)
Our vision is to foster systemwide collaboration to drive transformation of lung cancer prevention, therapeutic advances and care—including disparities in access to precision treatment.
- Novel Therapeutics
- Population Health and Policy
- Screening and Prevention Taskforce
- Tumor Biology